Radiation therapy is one of the most significant cancer treatments. It is often prescribed in combination with chemotherapy and/or surgery for the maximum effectiveness. Radiotherapy focuses on destroying cancer cells and increasing life expectancy of the patients. High prevalence of cancer may boost applications of this therapy. Moreover, technological advancements are anticipated to influence adoption of radiation oncology as the primary treatment of cancer.
Innovative delivery methods of radiotherapy are anticipated to improve effectiveness & safety. Major companies focus on introducing novel radiation technologies. Some of these techniques are already in use, while others need further research & study before they are approved for general usage.
Hyperthermia:-
This treatment utilizes heat for the treatment of different types of cancer. Heat is helpful for removing cancer cells. However, it is not too effective when used without any supplementary therapy. Currently, researchers are studying the heat generated by ultrasound & microwaves to determine its effectiveness with radiation oncology. This can improve the results of the radiation therapy in the near future.
Hyperbaric Oxygen Therapy (HBOT):-
It involves breathing pure & clean oxygen under controlled surroundings. HBOT is carried out in a chamber that is sealed and pressurized at 1½ to 3 times the usual atmospheric pressure. These conditions can improve the sensitivity & response of certain types of cancer to radiation. Research & development for HBOT can put more light on the effects of this therapy in reversing the damage caused to the healthy body tissues during radiation.
Radioprotectors:-
These substances can protect healthy tissues from the harmful effects of radiation. These drugs can protect normal cells from neck and head from exposure to radiation. Amifostine (Ethyol), a common radio protector, is already being used along with radiotherapy.
Market Insights:-
According to Grand View Research, Inc.; the global radiation oncology market is anticipated to grow at a substantial CAGR during the forecast period (2014 to 2025). Rapid technological developments, high healthcare expenditure, and preference for radiotherapy as the primary treatment can propel market growth. Nordion (Canada) Inc.; IsoRay, Inc.; Elekta AB; and Mallinckrodt Public Ltd. Company are some of the chief companies operating in the market.
No comments:
Post a Comment